- Interleukin-6 Antagonist
- Accession Number
- DBCAT003511 (DBCAT004463)
Drug Drug Description Siltuximab An interleukin antagonist used to treat multicentric Castleman's disease (MCD) in patients who are HIV and HHV-8 negative.
- Drugs & Drug Targets
Drug Target Type Siltuximab Interleukin-6 target Siltuximab Cytochrome P450 3A4 enzyme